Архивъ внутренней медицины (Apr 2013)

КАЧЕСТВО ЖИЗНИ ПАЦИЕНТОВ С ПРОЛАПСОМ МИТРАЛЬНОГО КЛАПАНА

  • А. И. Мартынов,
  • Е. В. Акатова,
  • О. П. Николин

DOI
https://doi.org/10.20514/2226-6704-2013-0-2-22-28
Journal volume & issue
Vol. 0, no. 2
pp. 22 – 28

Abstract

Read online

Patients with mitral valve prolapse (MVP) revealed a significant deterioration in the quality of life (QOL) compared with healthy people. After a course of the Magnerot, alprazolam (Xanax), psychotherapy significantly improve was estimated. In observing these same patients after 15 years recorded a decline in all QOL parameters compared to the results immediately after treatment and from baseline. However, patients with MVP who regularly used Magnerot over the years found a significant improvement of quality of life.

Keywords